"A member of the Sarah Cannon Blood Cancer Research Network, our Blood Cancer and Blood and Marrow Transplant Programs, also known as bone marrow or stem cell transplant, are committed to bringing you new and innovative treatment options. Consistently ranked among the top programs for blood and marrow transplant in the U.S., our program has completed over 4000 blood or marrow stem cell transplants since inception."

During the past decade, Blood Cancer and Stem Cell Transplant Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Blood Cancer and Stem Cell Transplant Clinic" are "Leukemia, Myeloid, Acute" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Blood Cancer and Stem Cell Transplant Clinic" in a lesser frequency.

Most popular intervention types in "Blood Cancer and Stem Cell Transplant Clinic" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Elranatamab" (1 trials), "Elranatamab+ dexamethasone" (1 trials), "HSCT" (1 trials), "Placebo" (1 trials) and "azacitidine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blood Cancer and Stem Cell Transplant Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Blood Cancer and Stem Cell Transplant Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Blood Cancer and Stem Cell Transplant Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blood Cancer and Stem Cell Transplant Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".